Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2010
11/10/2010EP2248887A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application
11/10/2010EP2248817A2 Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248816A2 2-ALKYLAMINO-3-ARYLSULFONYL-CYCLOALCANO [e OR ] PYRAZOLO [1,5-A] PYRIMIDINES / ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS, METHODS FOR THE PRODUCTION AND THE USE THEREOF
11/10/2010EP2248815A2 3-sulfonyl-pyrazolo[1,5-a]pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
11/10/2010EP2248814A2 SUBSTITUTED CYCLOALCANO[e AND d] PYRAZOLO [1,5-a] PYRIMIDINES/ANTAGONISTS OF SEROTONIN 5-HT6 RECEPTORS AND METHODS FOR PRODUCTION AND THE USE THEREOF
11/10/2010EP2248812A2 Fused cyclic compounds as GPR40 receptor modulators
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248798A1 Novel lipid compounds
11/10/2010EP2248524A2 Preventives/remedies for stress urinary incontinence and method of screening the same
11/10/2010EP2247602A2 Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
11/10/2010EP2247597A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/10/2010EP2247580A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247295A1 Composition for improving liver metabolism and diagnostic method
11/10/2010EP2146997B1 Substituted furo[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010EP1937659B1 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
11/10/2010EP1916913B1 Protein composition for treating a physiologically caused, clinically normal increased need for protein
11/10/2010EP1912991B1 Xanthine derivatives as selective hm74a agonists
11/10/2010EP1896445B1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
11/10/2010EP1888582B1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
11/10/2010EP1653944B1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
11/10/2010EP1643997B1 Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus
11/10/2010EP1633340B1 Compounds for the treatment of metabolic disorders
11/10/2010EP1569692B1 Betaine and salicylic acid compositions
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases
11/10/2010CN1989129B A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate salt
11/10/2010CN1939435B Hypolipidemic composition and its use
11/10/2010CN1913879B Compositions and pharmaceutical uses for treating diabetes
11/10/2010CN1846518B Plum food producing process
11/10/2010CN1799549B Process for preparing soybean isoflavone phospholipid composition
11/10/2010CN1569884B Method for preparing astragaloside and its use in preparation of drug for preventing and treating diabetic nephropathy
11/10/2010CN1552315B 治疗组合物 The therapeutic composition
11/10/2010CN101883772A Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
11/10/2010CN101883762A Benzothiazoles as ghrelin receptor modulators
11/10/2010CN101883609A Rapid acting injectable insulin compositions
11/10/2010CN101883575A Guava extract
11/10/2010CN101883571A Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin
11/10/2010CN101883493A Dough composition
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101879428A Method for preparing carotenoid microcapsules with controllable isomer proportion
11/10/2010CN101879310A Application of human urinary kallidinogenase in preparing medicine for treating diabetic nephropathy
11/10/2010CN101879309A Application of human urinary kallidinogenase in preparing medicine for treating diabetic foot ulcers
11/10/2010CN101879286A Special wine for adjusting human spirit and preparation process thereof
11/10/2010CN101879280A Composition for nourishing kidney, replenishing vital essence, promoting mentality and calming nerves, and preparation method
11/10/2010CN101879278A Medicine composition with hyperglycemic function, and preparation method and application thereof
11/10/2010CN101879275A Medicine composition with hyperglycemic function and preparation method thereof
11/10/2010CN101879231A Pharmaceutical composition having function of reducing blood fat and preparation method thereof
11/10/2010CN101879221A Medical application of caulis polygoni multiflori
11/10/2010CN101879212A Compound walnut and linseed oil fat emulsion intravenous injection and preparation method thereof
11/10/2010CN101879208A Method for extracting total flavonoids from mung bean shell
11/10/2010CN101879207A Pharmaceutical composition having function of reducing blood fat
11/10/2010CN101879193A Traditional Chinese medicine composite with function of inhibiting alpha-glucuroide and xanthine oxidase and preparation method and applications thereof
11/10/2010CN101879191A Medicinal composition
11/10/2010CN101879190A Composition containing curcumin and application of curcumin in preparing composition for adjusting blood sugar
11/10/2010CN101879188A Processing technology of multipurpose plant soluble powder
11/10/2010CN101879183A Diabetes mellitus treatment medicament formed by matching alpha-ricinoleic acid ethyl ester with chitosan
11/10/2010CN101879178A Medicinal application of timosaponin BIII
11/10/2010CN101879165A Novel antihypertensive medicament compound preparation
11/10/2010CN101879162A Weight-losing medicament formed by matching alpha-ricinoleic acid ethyl ester with berberine
11/10/2010CN101879158A New application of artemisinin derivant
11/10/2010CN101879157A Application of kaempferol
11/10/2010CN101878906A Health care food with auxiliary hyperglycemic function and preparation method thereof
11/10/2010CN101878831A Pu'er and bitter gourd tea and production method thereof
11/10/2010CN101878790A Nutrification flour for diabetics and preparation method thereof
11/10/2010CN101584688B Medicament composition for treating diabetes and complications of diabetes
11/10/2010CN101505764B Drug composition for treating 2 type diabetes and its chronicity neopathy
11/10/2010CN101502497B Fenofibrate medicament composition
11/10/2010CN101390985B Traditional Chinese medicine for treating diabetes acral necrosis
11/10/2010CN101390875B New use of organic salt and inorganic salt composite solution
11/10/2010CN101380339B Extraction method of Heidouba effective constituent
11/10/2010CN101352425B Compound osmotic pump controlled release preparation and preparation method thereof
11/10/2010CN101328487B Preparation of fermentation liquor of Coprinus comatus liquid conversion mulberry leaf and use thereof
11/10/2010CN101318922B Novel dipeptidyl peptidase restrainer, synthesizing process and uses thereof
11/10/2010CN101264147B Content detecting method for shazhajing hypolipemic capsule
11/10/2010CN101180062B Compound preparation for treating diabetes mellitus
11/10/2010CN101167796B Monascus and red sage root composition for preventing and treating cardiovascular and cerebrovascular diseases
11/10/2010CN101157710B Method for preparing iron supplementary carboxymethyl Chitosan oligosaccharide ferrous
11/10/2010CN101099775B Cardiac and cerebral vascular disease treating medicine
11/10/2010CN101099566B Lactucin and its preparation method and application
11/10/2010CN101090718B Complex formulation of 3-hydroxy-3-methyl glutaryl coa reductase inhibitor and antihypertensive agent, and process for preparing same
11/10/2010CN101085041B Total alkaloid of lotus leaves extraction and its preparation method
11/10/2010CN101085039B Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method
11/10/2010CN101057643B Rice with blood sugar reducing function
11/10/2010CN101053598B Medicinal composition for treating cardio-cerebralvascular diseases and diabetes
11/10/2010CN101049440B Preparation of Chinese traditional medicine in use for diabetes, and preparation method
11/10/2010CN101039902B Aminoalcohol derivatives
11/10/2010CA2759843A1 Gpr 119 modulators
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829572 Hypoparathyroidism, osteoporosis, osteopenia, periodontal disease, Paget's disease, bone fracture, osteoarthritis, rheumatoid arthritis, and humoral hypercalcemia of malignancy; e.g. (R)-3-(1-(3,4-difluorophenyl) propan-2-yl)-2-(3-hydroxypyridin-2-yl) 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one
11/09/2010US7829568 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010CA2594684C Morpholines as 5ht2c agonists
11/09/2010CA2540845C Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/09/2010CA2493958C Muscarinic agonists
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2458209C Compositions comprising pectin and ascorbic acid
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 1298